Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Antitumor Efficacy of Docetaxel-loaded Nanocarrier against Esophageal Cancer Cell Bearing Mice Model.
[esophageal carcinoma]
Esophageal
carcinoma
is
one
of
the
most
prevalent
cancers
with
high
rate
of
mortality
worldwide
.
Intravenous
and
oral
-based
chemotherapeutic
regimens
were
employed
;
however
all
the
current
treatment
modalities
are
largely
unsuccessful
.
Therefore
the
main
aim
of
this
work
was
to
demonstrate
the
antitumor
efficacy
of
docetaxel
(
DTX
)
-
loaded
trimethyl
chitosan
(
TMC-DTX
)
against
EC
9701
esophageal
squamous
cancer
cells
.
We
showed
a
superior
anti-proliferative
activity
for
TMC-DTX
against
EC
9701
cells
upon
incubation
for
24
,
48
,
and
72
 
h
.
Notably
,
nanoparticles
effectively
killed
the
cancer
cells
at
longer
incubation
time
which
was
consistent
with
the
fact
that
much
of
the
cells
enter
G
2
and
M
phase
at
longer
incubation
at
which
DTX
is
most
effective
.
Furthermore
,
Annexin
V
/
PI
based
cell
apoptosis
study
further
confirmed
the
enhanced
anticancer
activity
of
DTX
formulations
.
Cell-cycle
analysis
showed
a
substantial
proportion
of
cells
in
subG
0
and
G
2
/
M
phase
of
cell
arrest
.
Importantly
,
TMC-DTX
showed
a
remarkable
tumor
regression
profile
in
EC
9701
tumor
bearing
mice
.
The
intravenous
administration
significantly
controlled
/
delayed
the
growth
of
tumor
by
comparison
to
free
drug
.
Therefore
TMC-DTX
could
a
potential
drug
delivery
system
to
enhance
the
chemotherapeutic
efficacy
in
esophageal
carcinoma
.
Diseases
Validation
Diseases presenting
"high rate"
symptom
alpha-thalassemia
classical phenylketonuria
cohen syndrome
congenital adrenal hyperplasia
congenital diaphragmatic hernia
cystinuria
dystrophic epidermolysis bullosa
erythropoietic protoporphyria
esophageal carcinoma
homocystinuria without methylmalonic aciduria
hydrocephalus with stenosis of the aqueduct of sylvius
inclusion body myositis
krabbe disease
liposarcoma
omenn syndrome
papillon-lefèvre syndrome
primary effusion lymphoma
primary hyperoxaluria type 1
proteus syndrome
pyomyositis
thoracic outlet syndrome
trochlear dysplasia
x-linked adrenoleukodystrophy
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom